|
|
|
Insider
Information: |
Spiegelman Daniel K |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
148,092 |
|
Indirect Shares
|
6,673 |
|
|
Direct
Value |
$5,100,357 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
154,765 |
|
|
Total
Value |
$5,100,357 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
CV Therapeutics Inc |
CVTX |
SVP, CFO |
2009-04-09 |
67,489 |
2009-04-09 |
6,673 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
Director |
2018-03-09 |
0 |
2009-12-04 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2019-04-30 |
47,686 |
2012-05-29 |
0 |
Premium* |
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2015-06-04 |
0 |
Premium* |
|
Myriad Genetics Inc |
MYGN |
Director |
2024-06-04 |
32,917 |
2020-05-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
182 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-02-29 |
4 |
D |
$81.87 |
$3,828,732 |
D/D |
(46,766) |
54,311 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-03-02 |
4 |
AS |
$86.12 |
$398,120 |
D/D |
(4,623) |
49,688 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-03-03 |
4 |
D |
$89.57 |
$214,520 |
D/D |
(2,395) |
47,293 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,640 |
63,933 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-04-29 |
4 |
A |
$51.26 |
$10,355 |
D/D |
202 |
64,135 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-05-13 |
4 |
D |
$82.71 |
$142,427 |
D/D |
(1,722) |
62,413 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-05-23 |
4 |
AS |
$87.07 |
$328,184 |
D/D |
(3,769) |
58,644 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-05-27 |
4 |
D |
$89.09 |
$383,532 |
D/D |
(4,305) |
54,339 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-05-31 |
4 |
AS |
$89.35 |
$1,873,126 |
D/D |
(20,841) |
50,394 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-05-31 |
4 |
OE |
$39.06 |
$659,958 |
D/D |
16,896 |
71,235 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-06-03 |
4 |
D |
$90.00 |
$162,090 |
D/D |
(1,801) |
48,593 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-06-06 |
4 |
AS |
$89.14 |
$146,992 |
D/D |
(1,649) |
46,944 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-08-01 |
4 |
AS |
$99.33 |
$397,320 |
D/D |
(4,000) |
42,944 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-10-31 |
4 |
A |
$68.44 |
$10,677 |
D/D |
156 |
43,100 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2016-11-09 |
4 |
S |
$90.61 |
$1,812,206 |
D/D |
(20,000) |
23,100 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-01-09 |
4 |
AS |
$90.00 |
$450,000 |
D/D |
(5,000) |
18,100 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
12,247 |
30,347 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-02-28 |
4 |
AS |
$94.00 |
$2,820,000 |
D/D |
(30,000) |
30,347 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-02-28 |
4 |
OE |
$63.10 |
$1,893,000 |
D/D |
30,000 |
60,347 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-03-01 |
4 |
AS |
$94.50 |
$472,500 |
D/D |
(5,000) |
25,347 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-03-03 |
4 |
D |
$93.95 |
$214,488 |
D/D |
(2,283) |
23,064 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-03-06 |
4 |
AS |
$93.32 |
$214,916 |
D/D |
(2,303) |
20,761 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-03-15 |
4 |
D |
$92.50 |
$397,843 |
D/D |
(4,301) |
16,460 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-03-16 |
4 |
AS |
$91.96 |
$182,908 |
D/D |
(1,989) |
14,471 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2017-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
12,200 |
26,671 |
0 |
- |
|
182 Records found
|
|
Page 3 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|